Romania might have a fourth anti-Covid vaccine available by April, the one produced by Johnson & Johnson, the coordinator of the national vaccination campaign, military doctor Valeriu Gheorghiță told Digi FM.
The doctor said that the vaccine produced by Johnson & Johnson is expected to be authorized by the European Medicines Agency in mid-March.
Gheorghita said that the Johnson & Johnson vaccine has a very high efficiency and it has only one dose to be administered.
Johnson & Johnson announced on February 16 that Janssen-Cilag International N.V., had submitted a conditional Marketing Authorisation Application (cMAA) to the European Medicines Agency (EMA) seeking authorisation for its investigational single-dose Janssen COVID-19 vaccine candidate. The submission is based on topline efficacy and safety data from the Phase 3 ENSEMBLE clinical trial.
If authorized, Janssen’s investigational single-dose vaccine is estimated to remain stable for two years at -20°C (-4°F), at least three months of which can be stored in most standard refrigerators at temperatures of 2°-8°C (36°F–46°F).